InterSystems is releasing global functionality for its TrakCare unified healthcare information system to screen and support patients with 2019-nCoV, the coronavirus infection that originated in Wuhan in China.
The functionality is available to users of the latest editions of TrakCare now, and customers in China and multiple other countries, including the UK and United Arab Emirates have already begun using it.
The functionality enables clinicians to screen patients for 2019-nCoV, using World Health Organisation (WHO) guidance, and a link to the Wuhan Coronavirus Global Cases tracking app provided by the Johns Hopkins Center for Systems Science and Engineering in the US.
Hazem El Oraby, chief medical officer for TrakCare at InterSystems said: “InterSystems keeps a close watch on the world’s healthcare requirements, so it can respond to issues that it can help to address in a timely manner. We are proud to have deployed this quickly for our users.
“This is a great example of how TrakCare can be updated in real-time to urgently respond to threats and deployed rapidly to the organisations and clinicians that need it; particularly those using the latest edition of our systems.”
Icons will indicate whether screening has been undertaken and the results. There is no generally accepted treatment for 2019-nCoV. However, the WHO is advising hospitals to isolate patients and protect others from infection, and the final element of the new TrakCare functionality will advise clinicians of any steps they should take.
As the number of people worldwide who have died of 2019-nCoV continues to rise, there has to date been very few confirmed cases in the UK, and no deaths.
Mike Fuller, marketing director, InterSystems UK, said: “The NHS is taking every precaution to avoid the spread of 2019-nCoV in the United Kingdom. We are proud to provide our TrakCare customers with this functionality to aid in this effort.”
